|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
22
|
|
pubmed:dateCreated |
1999-1-26
|
|
pubmed:abstractText |
In a 3-oxo-1,4-benzodiazepine-2-acetic acid series of vitronectin receptor (alpha v beta 3) antagonists containing a benzimidazole as a novel arginine mimetic, we examined the effects of benzimidazole modifications and amide substitutions on both activity and pharmacokinetics.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0960-894X
|
|
pubmed:author |
pubmed-author:AliF EFE,
pubmed-author:BondinellW EWE,
pubmed-author:CallahanJ FJF,
pubmed-author:CalvoR RRR,
pubmed-author:CousinsR DRD,
pubmed-author:HwangS MSM,
pubmed-author:JakasD RDR,
pubmed-author:KeenanR MRM,
pubmed-author:KwonCC,
pubmed-author:LIT HTH,
pubmed-author:LohrJ TJT,
pubmed-author:MillerW HWH,
pubmed-author:NguyenT TTT,
pubmed-author:ReaderV AVA,
pubmed-author:RiemanD JDJ,
pubmed-author:RossS TST,
pubmed-author:SmithB RBR,
pubmed-author:TakataD TDT,
pubmed-author:UzinskasI NIN,
pubmed-author:YuanC CCC
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
17
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3165-70
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonists.
|
|
pubmed:affiliation |
Research & Development Division, SmithKline Beecham Pharmaceuticals, Collegeville, PA 19426-0989, USA.
|
|
pubmed:publicationType |
Journal Article
|
